Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Quarterly Sales
CRO
WuXi AppTec posts sales decline but picks up new business in Q3
With the specter of the BIOSECURE Act clouding its future, China’s WuXi AppTec sustained its fourth straight quarter with a revenue decline.
Kevin Dunleavy
Oct 29, 2024 8:25am
Abbott clings to billion-dollar COVID test sales a little longer
Jul 20, 2022 11:37am
Dexcom keeps up the pace as it plots global CGM launches
Apr 29, 2022 11:47am
Hologic M&A to pick up slack from future COVID testing declines
Apr 28, 2022 12:30pm
Roche sees COVID test gains but preps for sales to dry up
Apr 25, 2022 10:45am
Abbott's COVID test sales reach all-time high
Apr 20, 2022 10:23am
